Jaroslav Janda Selected Research

Jaroslav Janda Research Topics

7	Neoplasms (Cancer) 01/2018 - 02/2012
5	Carcinogenesis 01/2018 - 10/2012
3	Skin Neoplasms (Skin Cancer) 11/2016 - 09/2014
1	Ischemia 11/2022
1	Acute Kidney Injury (Acute Renal Failure) 11/2022
1	Thrombosis (Thrombus) 09/2021
1	Flushing 09/2021
1	Infections 09/2021
1	Pathologic Constriction (Stenosis) 09/2021
1	Sepsis (Septicemia) 09/2021
1	Neointima 09/2021
1	Inflammation (Inflammations) 11/2016
1	Wounds and Injuries (Trauma) 05/2016
1	Colonic Neoplasms (Colon Cancer) 11/2015
1	Multiple Myeloma 08/2012

3	Mitochondrial DNA (mtDNA)IBA 11/2014 - 02/2012
2	Toll-Like Receptor 4IBA 01/2018 - 11/2016
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 03/2013
2	AntioxidantsIBA 05/2016 - 08/2012
2	Arginine (L-Arginine)FDA Link 11/2014 - 02/2012
2	Transfer RNA (tRNA)IBA 11/2014 - 02/2012
1	Formoterol Fumarate (Oxis)FDA Link 11/2022
1	CreatinineIBA 11/2022
1	FibrinIBA 09/2021
1	VimentinIBA 09/2021
1	ethyl 6- (N- (2- chloro- 4- fluorophenyl)sulfamoyl)cyclohex- 1- ene- 1- carboxylateIBA 01/2018
1	4- dodecyl- N- (1,3,4- thiadiazol- 2- yl)benzenesulfonamideIBA 03/2016
1	Sirolimus (Rapamycin)FDA Link 03/2016
1	sulforaphaneIBA 11/2015
1	Neutralizing AntibodiesIBA 11/2014
1	sandalwood oilIBA 09/2014
1	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 09/2014
1	santalolIBA 09/2014
1	Peptidyl-Prolyl Isomerase DIBA 03/2013
1	Interleukin-2 (IL2)IBA 08/2012
1	ResveratrolIBA 08/2012
1	Arg Transfer RNAIBA 02/2012
1	Biological ProductsIBA 02/2012
1	NucleotidesIBA 02/2012